Articles by Tim Burroughs
AVCJ daily bulletin returns April 7
AVCJ's daily bulletin is taking a short break for the Easter holiday. Publication will resume on April 7.
Applied terminates acquisition of Japan's Kokusai Electric
KKR’s $3.5 billion sale of Japanese semiconductor industry supplier Kokusai Electric to US-listed Applied Materials has fallen through due to regulatory approval issues in China.
IMM set for $222m exit from Korea's Taihan Electric Wire
IMM Private Equity has agreed to sell its 40% stake in Taihan Electric Wire, a Korea-based manufacturer of high-voltage cables to Hoban Construction for KRW251.8 billion ($222 million).
Fund focus: CityU promotes entrepreneur enablement
City University of Hong Kong plans to invest $64 million in creating 300 start-ups over the next three years, offering students and staff a more structured route to commercializing academic research
Deal focus: Affinity to close JobKorea's technology gap
When Affinity Equity Partners was drawing up plans for JobKorea, it found Seek’s product innovations in Australia a useful reference point. This gave context to a $795 million acquisition
Deal focus: IvyCap's timely 22x windfall
With the launch of its third fund a few weeks away, IvyCap Ventures leveraged strong investor interest in beauty e-commerce player Purplle to secure one of India’s largest rupee VC exits
VMS leads $190m round for China CDMO player Chime
VMS Group, a Hong Kong-based asset manager, has led a $190 million extended Series A round of funding for Chime Biologics, a Chinese contract development and manufacturing organization (CDMO).
Wise Road agrees $1.4b take-private of Korea chipmaker
Wise Road Capital, a China-based private equity firm that focuses on high-tech investments, has agreed to privatize Korea’s Magnachip Semiconductor Corporation at a valuation of $1.4 billion.
China's Zhihu completes $522m IPO, endures volatile debut
Chinese question-and-answer platform Zhihu endured a difficult New York Stock Exchange debut, closing at a 10.5% discount to its IPO price on a day when US-listed Chinese stocks fluctuated wildly.
PE topples advisory as China Renaissance's key business
Fund management has become China Renaissance’s largest source of revenue, seven years after the firm – best known for providing private placement and M&A advisory services to Chinese internet companies – entered the private equity business.
Baring targets $8.5b for eighth pan-Asia fund
Baring Private Equity Asia is back in the market seeking $8.5 billion for its eighth pan-regional fund, less than 15 months after closing Fund VII at $6.5 billion.
China autonomous driving start-up TuSimple files for US IPO
TuSimple, a China and US-based developer of autonomous driving technology for trucks, has filed for a US IPO. Its backers include CDH Investments, Zhiping Capital, Sina Corporation, and Hong Kong hedge fund Composite Capital.
India's Dream Sports raises $400m, hits $5b valuation
Dream Sports, operator of India’s largest fantasy sports platform, has raised $400 million in funding led by TCV, D1 Capital Partners and Falcon Edge Capital. The post-deal valuation is nearly $5 billion.
Hony launches China healthcare, consumer SPAC
Hony Capital has joined a string of Chinese private equity managers with special purpose acquisition vehicles (SPACs), targeting $300 million for healthcare and consumer deals.
Asian GPs prioritize portfolio resilience - Bain & Co
Three out of five GPs in Asia Pacific would be willing to forego at least 5% of near-term profit if that sum could be invested in making their portfolio companies more resilient across a range of metrics.
Australia's Airwallex sees valuation hit $2.6b
Airwallex, an international payments technology provider that launched out of Melbourne, has closed a third tranche of Series D funding, taking the overall round to $300 million and its valuation to $2.6 billion.
Q&A: OMERS' Ani Deshmukh
Ontario Municipal Employees Retirement System (OMERS) recently backed a spinout of Olympus Capital Asia’s credit team as Orion Capital Asia. Ani Deshmukh, a director with the Canadian pension fund, explains its regional strategy
Brookfield hires ex-Blackstone executive to lead China PE
Alex Yang, formerly a senior managing director at The Blackstone Group, has been recruited by Brookfield Asset Management to lead its private equity business in China.
China's Connect Biopharma gains 8% on debut after $191m US IPO
Connect Biopharma, a China-headquartered drug developer specializing in treatments for T cell-driven inflammatory diseases, gained 8.8% on debut following a $191.3 million US IPO.
China autonomous driving developer Momenta raises $500m
SAIC Motor, Toyota Motor Corporation, Robert Bosch, Yunfeng Capital, and Temasek Holdings are among the investors in a $500 million Series C funding round for Chinese autonomous driving technology developer Momenta.
China's Tuya completes $915m IPO, gains on debut
Tuya, a Chinese start-up that claims to be the world’s largest platform-as-a-service (PaaS) provider in terms of number of smart devices powered, raised $915.4 million in its US IPO. The offering was priced above the indicative range yet still registered...
Carlyle gets $543m through partial exit from India's SBI Card
The Carlyle Group has sold approximately one-quarter of its remaining 15.8% stake in SBI Cards & Payment Services – a year after the Indian company’s IPO – for INR39.4 billion ($543 million).
Temasek leads round for China marketing content start-up
Tezign, a Chinese start-up that serves as a content-focused one-stop marketing solutions platform, has closed a second tranche of Series C funding that takes the overall total for the round to $100 million.
China biotech makes Asia global healthcare PE leader
A more than 100% year-on-year increase in deal volume saw Asia Pacific overtake North America to become the most active global private equity healthcare market for the first time in 2020.